Special Notice.pdf
PDF 522 KB Posted
- Solicitation number
- PHX-SS-23-002
View the file
Other files
| File | Type | Posted |
|---|---|---|
| BPA Table of Estimated Supplies.pdf | ||
| JNA_Redacted.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
SPECIAL NOTICE
INTENT TO SOLE SOURCE
This is a notification of an intent to award a contract to Cepheid, under NAICS code 325413 In-Vitro Diagnostic Substance
Manufacturing by Indian Health Services under the authority of FAR 6.302-1, Only One Responsible Source. This requirement is to secure molecular diagnostic reagent test kits and consumables compatible with the Cepheid GeneXpert Xpress platform.
Test kits include COVID-19 or Combination test kits used to test for COVID-19, Influenza A+B, and Respiratory Syncytial
Virus and sexually transmitted infections, and other clinically significant bacterial infection detections such as Methicillin-
Resistant S. aureus (MRSA) and C. difficile.
If you can provide the supplies requested, all responsible sources may submit a capability statement, which shall be considered by the Agency and may be e-mailed to Ashley.Velasquez@ihs.gov referencing notice number PHX-SS-23-002 by 8 AM PDT, October 27, 2022. A determination by the Government not to compete this proposed contract acquisition based upon responses to the notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. This notice does not obligate the Government to award a contract or otherwise pay for information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed. Information provided will be used to assess tradeoffs and alternatives available for the potential requirement and may lead to the development of a solicitation.
Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted.
Any solicitation resulting from the analysis of information obtained will be announced to the public in Federal Business
Opportunities in accordance with the FAR Part 5. However, responses to this notice will not be considered adequate responses to a solicitation. No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
Phoenix Area IHS – BPA Estimated Supplies Base Year
Phoenix
Indian Med Ctr
Whiteriver Hospital
Hopi Health Care Ctr
Parker Hospital
Peach Springs
Health Ctr
Fort Duchesne Health Ctr
Fort Yuma Health Ctr
Supply Description Catalog Number Estimated Qty
Estimated Qty
Estimated Qty
Estimated Qty
Estimated Qty
Estimated Qty
Estimated Qty
KIT,CARBA-R,IVD,GX BXCARBAR-10
KIT,CDIFF/EPI,GX,IVD,10-TEST BXCDIFF/EPI-10
KIT,CDIFF,10-TESTS,GX,IVD GXCDIFFICILE-
10-TESTS,GX,IVD
13 6 8
KIT,CT/NG,GX,IVD GXCT/NG-10
840 343 119 36 21 35
KIT,EV,10-TESTS,GX,IVD GXEV-100N-10
KIT,FII/FV,10-TESTS,GX,IVD GXFIIFV-10
KIT,GBS 10-TESTS,GX,IVD GXGBS-100N-10
7 6
KIT,GBS LB,10-TESTS,GX,IVD GXGBS-LB-10
42 21
KIT,MRSA,10-TESTS,GX,IVD GXMRSA-100N-
KIT,10-TEST,MRSA NXG,IVD,GX GXMRSA-NXG-
KIT,MRSA,10-TESTS,GX,IVD GXMRSA-100N-
KIT,MRSA/SA SSTI,10-
TESTS,GX,IVD
GXMRSA/SA-
SSTI-10
70 8 21 28 18 5
KIT,MTB,IVD,US GXMTB/RIF-US-
KIT,SA COMP,10-TESTS,GX,IVD GXSACOMP-10
9 35 5
Phoenix
Indian Med Ctr
Whiteriver Hospital
Hopi Health Care Ctr
Parker Hospital
Peach Springs
Health Ctr
Fort Duchesne Health Ctr
Fort Yuma Health Ctr
Supply Description Catalog Number Estimated Qty
Estimated Qty
Estimated Qty
Estimated Qty
Estimated Qty
Estimated Qty
Estimated Qty
KIT,XPERT TV_US,10-TEST GXTV-10
147 9
KIT,XPRESS,COV-2/FLU/RSV
PLUS,10 TEST
XP3COV2/FLU/RSV-
2800 1400 448 540 420 182 119
KIT,XPRESS,SARS-COV-2
PLUS,10-TEST
XP3SARS-COV2-10 350 315 182 91 45 70 45
KIT,XPRESS,FLU,US-IVD,10 TEST XPRSFLU-10
KIT,XPRESS,FLU/RSV,US-IVD,10
TEST
XPRSFLU/RSV-10 5
KIT,XPRESS,STREPA,US-IVD,10
TEST
XPRSTREPA-10 406 50
ESW AB,LIQUID AMIES,
FLOCKED,COPAN,480CFA
480CFA 6 6
CEPHEID COLLECTION DEVICE 900-0370
12 4 4 11 4 4
BUNDLE,OEM CONTROL
REAGENTS,MRSA/SA
MRSA/SA-BU1 4
A CASE OF CEPHEID
COLLECTION DEVICE
SWAB-500 12
NP swab collection kit for Xpert Flu, Xpert FLU/RSV, Xpert Xpress FLU/RSV
SWAB/B-100 44 23 19 11 4 5
NASAL SWAB AND TRANSPORT
MEDIUM, 100/KIT
SWAB/F-100 232 126 118 88 18 5 6
COLLECTION KIT, XPERT
SWAB,US CE IVD,50
SWAB/G-50 2100 24 13 4 4
CollectionKitA urine URINE/A-50
525 54 21 8 6 8
TEST KIT DESCRIPTION:
Critical Infectious Diseases
• Xpert® EV - Fast molecular in vitro diagnostic enteroviral meningitis test
• Xpert MTB/RIF - Accurate detection of MTB and Rifampin resistance mutations
• Xpert Xpress Flu^ - Accurate and reliable detection of Flu A and Flu B, in as soon as 20 minutes#
• Xpert Xpress Flu/RSV^ - Accurate and reliable detection of Flu A, Flu B, or RSV in as soon as 20 minutes†
• Xpert Xpress SARS-CoV-2‡ - A rapid, near-patient test for the detection of the 2019 novel coronavirus that causes COVID-19#
• Xpert Xpress CoV-2/Flu/RSV plus‡- Actionable, rapid respiratory results to meet the challenges of the ongoing pandemic**
• Xpert Xpress Strep A^ - Qualitative real-time PCR test providing accurate detection of Group A Streptococcus in as soon as 18 minutes# Oncology & Genetics
• Xpert BCR-ABL Ultra - Sensitive and quantitative monitoring of BCR-ABL mRNA in patients with chronic myelogenous leukemia (CML)
• Xpert BCR-ABL Ultra p190^^ (RUO) - Quantitative assay for the BCR-ABL minor breakpoint (p190) transcript
• Xpert FII & FV - 30-minute test for genetic risk of thrombosis Women's & Sexual Health
• Xpert TV - Fast and accurate diagnosis of trichomoniasis for both women and men in about 40 minutes#
• Xpert CT/NG - 90-minute detection and differentiation of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG)
• Xpert GBS - For direct intrapartum screening in labor/delivery
• Xpert GBS LB - For antepartum screening Healthcare-Associated Infections
• Xpert C. difficile - Detection of Clostridium difficile in as soon as 40 minutes#
• Xpert C. difficile/Epi - 45-minute detection & differentiation of Clostridium difficile and the Epidemic 027 strain
• Xpert Carba-R - qualitative, on-demand, real-time PCR test for the detection and differentiation of KPC, NDM, VIM, OXA-48, and IMP in 48 minutes
• Xpert MRSA NxG - Accurate, fast, on-demand PCR test that detects Methicillin-resistant Staphylococcus aureus (MRSA) directly from nasal swabs
• Xpert MRSA/SA Blood Culture - Accurate detection of Staphylococcus aureus (SA) and MRSA in positive blood culture specimens in about an hour
• Xpert MRSA/SA SSTI – Detection of MRSA & SA skin and soft tissue infections in about one hour
• Xpert Norovirus - Rapid identification and differentiation of Norovirus GI and GII in less than one hour
• Xpert SA Nasal Complete - presurgical testing of S. aureus and MRSA in about an hour
• Xpert vanA - The first rapid and accurate test to assist with VRE surveillance
File details come from the government source that posted it. Updated .